Pucotenlimab
Pucotenlimab is Lepu Biopharma's PD-1 antibody, approved in China in 2022 for mismatch-repair-deficient solid tumours and for melanoma, and in a phase 3 trial in colorectal cancer.
Overview
Taizhou Hanzhong (Lepu Biopharma) developed pucotenlimab (HX008), approved by the NMPA in July 2022 for previously treated MSI-high or mismatch-repair-deficient advanced solid tumours, China's first tissue-agnostic PD-1 approval, and for unresectable or metastatic melanoma after prior therapy. A phase 3 trial in metastatic colorectal cancer is registered.
Blocks PD-1 on T cells so tumour cells cannot switch them off through PD-L1. Connects to PD-1.
1.Pucotenlimab binds PD-1.
Compare all products across the US, EU, UK, Japan, China and Australia →
Approvals
| Region | Year | Indication |
|---|---|---|
| CN | 2022 | Previously treated MSI-high or dMMR advanced solid tumours; unresectable or metastatic melanoma after prior therapy |
Trials
topTrials recruiting now
Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.
Landmark trials
Latest papers
topQuery for this drug: (TITLE:"Pucotenlimab" OR ABSTRACT:"Pucotenlimab" OR TITLE:"HX008" OR ABSTRACT:"HX008") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Pucotenlimab, not a curated reading list.
Similar pages
not linked directly; found by shared links- TreatmentMRG003
Shares A Study of MRG003 in Combination With Pucotenlimab Versus Chemotherapy in the Treatment of Patients With Recurrent or Metastatic Nasopharyngeal Carcin and the tag pipeline.
- TreatmentIBI363
Shares PD-1, Melanoma, Colorectal cancer and the tag pipeline.
- TreatmentT3011
- TreatmentBCD-217
- TreatmentGC101 TIL
- TreatmentTunlametinib
Shares Melanoma, Colorectal cancer and the tag pipeline.
- TreatmentFavezelimab
Shares Immune checkpoint inhibitors, Colorectal cancer and the tag pipeline.
- TreatmentJK08
Shares Melanoma, Colorectal cancer and the tag pipeline.